Which body oversees the selection of nonproprietary names for new drugs?

Prepare effectively for the FPGEE Management Test. Utilize flashcards and multiple-choice questions with detailed explanations. Ace your upcoming exam!

The body responsible for overseeing the selection of nonproprietary names for new drugs is the United States Adopted Names (USAN) Council. This organization works in collaboration with the FDA and other entities to develop and maintain a standardized nomenclature for drugs that ensures clarity and avoids confusion in drug naming.

The nonproprietary name, often referred to as the generic name, is important as it provides a uniform way to identify the active ingredient in a drug product, which helps healthcare providers and patients communicate effectively about medications. The USAN Council assesses various scientific and practical factors when considering a name for a new drug, including uniqueness, potential for confusion with other drug names, and the drug's chemical characteristics.

In this context, the USAN Council plays a critical role in the drug approval process by ensuring that the names assigned to medications facilitate safe prescribing and dispensing practices, thereby protecting public health.

Subscribe

Get the latest from Examzify

You can unsubscribe at any time. Read our privacy policy